MODERN PRINCIPLES OF ALLERGIC RHINITIS THERAPY IN CHILDREN

The article is dedicated to allergic rhinitis (AR) in children. AR is widespread among children and adolescents; it negatively affects physical and psychological condition, social life and school performance and reduces life quality of both patients and members of their families. The authors consider the most modern approaches to diagnostics and control over the disease and present evidence-based recommendations. The authors offer the relevant classification; describe classic and additional disease symptoms and list the key nosological forms of differential diagnostic search. The complex of therapeutic measures to be taken at AR is aimed at relieving devastating symptoms of the disease and involves limitation of contacts with pathogenetically significant allergens, drug therapy, specific immunotherapy and education. Preventive measures are aimed at preventing development of sensitization/manifestation/aggravation of the AR course. The information given in the article is aimed at spreading the main principles of AR therapy and increasing accessibility of the modern methods of control over allergic diseases.

Key words: allergic rhinitis; children; control; therapy

1. Bousquet J., Khaltaev N., Cruz A. A., Denburg J., Fokkens W. J., Togias A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen). Allergy. 2008; 63 (Suppl. 86): 8–160.

2. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Brozek J. L., Bousquet J., Baena-Cagnani C. E., Bonini S., Canonica G. W., Casale T. B., van Wijk R. G., Ohta K., Zuberbier T., Schunemann H. J. Global Allergy and Asthma European Network, Grading of Recommendations Assessment, Development and Evaluation Working Group SOJ. Allergy Clin. Immunol. 2010; 126 (3): 466.

3. Allergiya u detei: ot teorii — k praktike. Pod red. L.S. Namazovoi-Baranovoi [Allergy in Children: from Theory to Practice. Edited by L.S. Namazova-Baranova]. Мoscow, Union of Pediatricians of Russia, 2010–2011. 668 p.

4. Namazova-Baranova L.S., Ogorodova L.M., Tomilova A.Yu., Deev I.A., Alekseeva A.A., Vishneva E.A., Gromov I.A., Evdokimova T.A., Kamaltynova E.M., Kolomeets I.L., Torshkhoeva R.M. Prevalence astmapodobnyh simtomov and diagnosed asthma in the adolescent population. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2009; 6 (3): 59–65.

5. Roberts G., Xatzipsalti M., Borrego L. M., Custovic A., Halken S., Hellings P. W., Papadopoulos N. G., Rotiroti G., Scadding G., Timmermans F., Valovirta E. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013; 68: 1102–1116.

6. Silva C. H. M., Silva T., Morales N., Fernandes K., Pinto R. Quality of life in children and adolescents with allergic rhinitis. Braz. J. Otorhinolaryngol. 2009;75: 642–649.

7. Ant K., Pearce N., Anderson H. R., Ellwood P., Montefort S., Shah J. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood ISAAC Phase Three. Allergy. 2009; 64: 123–148.

8. Durham S. R., Smurthwaite L., Gould H. J. Local IgE production. Am. J. Rhinol. 2000; 14: 305–307.

9. Shin S., Choi S., Hur G., Lee K., Kim S., Cho J. et al. Local production of total IgE and specific antibodies to the house dust mite in adenoid tissue. Pediatr. Allergy Immunol. 2009; 20: 134–141.

10. Bertelsen R., Lodrup C., Carlsen K. Rhinitis in children: co-morbidities and phenotypes. Pediatr. Allergy Immunol. 2010; 21: 612–622.

11. Modrzynski M., Zawisza E. The influence of birch pollination on the adenoid size in children with intermittent allergic rhinitis. Int. J. Pediatr. Otorhinolaryngol. 2007; 71: 1017–1023.

12. Shin S., Choi G., Lee K., Kim S., Cho J., Park H. IgE response to staphylococcal enterotoxins in adenoid tissues from atopic children. Laryngoscope. 2009; 119: 171–175.

13. Webber C. M., England R. W. Oral allergy syndrome: a clinical, diagnostic, and therapeutic challenge. Ann. Allergy Asthma Immunol. 2010; 104: 101–108.

14. Hellings P. W., Fokkens W. J., Akdis C., Bachert C., Cingi C., Dietz de Loos D. et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy. 2013; 68: 1–7.

15. Vogl T. J., Stemmler J., Heye B., Schopohl J., Danek A., Bergman C. et al. Kallman syndrome versus idiopathic hypogonadotropic hypogonadism at MR imaging. Radiology. 1994; 191: 53–57.

16. Astaf'eva N.G., Udovichenko E.N., Gamova I.V., Perfilova I.A., Naumova O.S., Kenesarieva Zh.M., Vachugova L.K., Gapon M.S. Allergic and non-allergic rhinitis: comparative characteristics. Lechashchii vrach = Practicing Doctor. 2013; 4: 10–12.

17. Simons F. E., Simons K. J. Histamine and H1-antihistamines: celebrating a century of progress. J. Allergy Clin. Immunol. 2011; 128: 1139–1150.

18. Ng K. H., Chong D., Wong C. K., Ong H. T., Lee C. Y., Lee B. W. et al. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, doubleblind, placebo-controlled comparative study. Pediatrics. 2004; 113: e116–e121.

19. Wandalsen G., Mendes A. I., Sole D. Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis. Am. J. Rhinol. Allergy. 2010; 24: e32–e36.

20. Meltzer E., Tripathy I., Maspero J., Wu W., Philpot E. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6–11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin. Drug. Invest. 2009; 29: 79–86.

21. Lohia S., Schlosser R. J., Soler Z. M. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a metaanalysis. Allergy. 2013; 68: 569–579.

22. Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann. Allergy Asthma Immunol. 2008; 100: 272–279.

23. Garavello W., Di B., Romagnoli M., Sambataro G., Gaini R. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Int. Arch. Allergy Immunol. 2005; 137: 310–314.

24. Li H., Sha Q., Zuo K., Jiang H., Cheng L., Shi J. et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL J. Otorhinolaryngol Relat. Spec. 2009; 71: 50–55.

25. Kulichenko T.V., Namazova-Baranova L.S., Torshkhoeva R.M., Lukina O.F., Vishneva E.A. Anti-IgE-treatment of severe asthma in children: two-year experience. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2010; 7 (3): 57–65.

26. Kulichenko T.V., Baranov A.A., Abelevich M.M., Balashova E.V., Vishneva E.A. et al. Generalized analysis using monoclonal antibodies to IgE in the treatment of asthma in children in Russian. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2011; 8 (2): 50–56.

27. Man L. X. Complementary and alternative medicine for allergic rhinitis. Current Opinion in Otolaryngology & Head & Neck Surgery. 2009; 17: 226–231.

28. Benninger M., Farrar J., Blaiss M., Chipps B., Ferguson B., Krouse J. et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann. Allergy Asthma Immunol. 2010;104: 13–29.

29. Di L. G., Pacor M. L., Pellitteri M. E., Morici G., Di G. A., Lo B. C. et al. Randomized placebocontrolled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin. Exp. Allergy. 2004; 34: 259–267.

30. Anolik R. Mometasone Furoate Nasal Spray With Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2008; 100: 264–271.

31. Van Cauwenberge P., Bachert C., Passalacqua G., Bousquet J., Canonica G. W., Durham S. R. et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000; 55: 116–134.

32. Calderon M. A., Gerth van Wijk R., Eichler I., Matricardi P. M., Varga E. M., Kopp M. V. et al. Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr. Allergy Immunol. 2012; 23: 300–306.

33. Hankin C., Cox L., Lang D., Levin A., Gross G., Eavy G. et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J. Allergy Clin. Immunol. 2008; 121: 227–232.

34. Hankin C., Cox L., Lang D., Bronstone A., Fass P., Leatherman B. et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann. Allergy Asthma Immunol. 2010; 104: 79–85.

35. Wong I. Y., Soh S. E., Chng S. Y., Shek L. P., Goh D. Y., van Bever H. P. et al. Compliance with topical nasal medication — an evaluation in children with rhinitis. Pediatr. Allergy Immunol. 2010; 21: 1146–1150.

36. Baranov A.A., Vishneva E.A., Namazova-Baranova L.S. Telemedicine – prospects and challenges at the new stage of development. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2013; 10 (3): 6–11.

37. Allergologiya i immunologiya. Pod red. A.A. Baranova i R.M. Khaitova. Soyuz pediatrov Rossii. 3-e izd., ispr. i dop. [Allergology and Immunology. Edited by А.А. Baranov and R.М. Khaitov. Union of Pediatricians of Russia. 3rd edition, revised and updated]. Moscow, Union of Pediatricians of Russia, 2011. 256 p.